Jamie Clark
Stock Analyst at Rothschild & Co
(2.52)
# 2,385
Out of 5,072 analysts
9
Total ratings
71.43%
Success rate
9.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $277.14 | +12.22% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $606.60 | -21.86% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $183.65 | +28.51% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $178.94 | +1.71% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $268.27 | +2.88% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $189.69 | +2.80% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $231.80 | +19.07% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $277.14
Upside: +12.22%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $606.60
Upside: -21.86%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $183.65
Upside: +28.51%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $178.94
Upside: +1.71%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $268.27
Upside: +2.88%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $189.69
Upside: +2.80%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $231.80
Upside: +19.07%